Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X
publication

A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent MPN.


Xiao, Wenbin et al.
Blood Advances (2020)
Abstract

  • Myeloid neoplasm (MPN) clones can evolve from acute myeloid leukemia to gain dominance with isocitrate dehydrogenase inhibition.
  • Pro-differentiation agents such as ivosidenib can unmask MPN sequelae.



Authors

Xiao, Wenbin, Miles, Linde A., Bowman, Robert L, Durani, Vidushi, Tian Helen S., DelGaudio, Nicole L, Mishra, Tanmay, Zhu, Menglei, Zhang, Yanming, Stump, Sarah E., Tallman, Martin S, Levine, Ross L., Cai, Sheng F.



VIEW

publication
Single-cell mutation analysis of clonal evolution in myeloid malignancies.
Miles, L. A.
Nature (2020)
publication
Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia
Wang, F.
BioRxiv (2020)
publication
Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis
Laura W. Dillon
MedRxiv (2020)
publication
Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics.
Morita, K.
Nature Communications (2020)
REQUEST QUOTE